HealthQuill Articles by: HealthQuill
More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood pressure, an official of not-for-profit, Resolve to Save Lives, said.
Drugs Health Pharma

‘Every hour 1,000 people die of stroke, heart attack due to high blood pressure’

HQ Team September 19, 2023: More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood

Read More
The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.
Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss

Read More
The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no longer automatically substitutable at the pharmacy due to increased toxicity.
Drugs Health Pharma

FDA rules Accord’s tacrolimus oral drug not “substitutable” for US market

HQ Team September 19, 2023: The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no

Read More
The Bill & Melinda Gates Foundation has given a grant of $44 million to GE Healthcare to create user-friendly, AI-assisted ultrasound imaging auto-assessment tools.
Drugs Health Pharma

GE Healthcare gets $44 million grant from Bill & Melinda Foundation

HQ Team September 18, 2023: The Bill & Melinda Gates Foundation has given a grant of $44 million to GE Healthcare to create

Read More
German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a  vaccine for mpox.
Drugs Health Pharma

Germany’s BioNTech, CEPI in $90m pact for mpox vaccine 

HQ Team September 18, 2023: German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Pharma

US cancer patients using alcohol pose new challenge for caretakers

Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency

Read More
The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.
Drugs Health Pharma

USFDA gives nod for GSK’s Ojjaara bone cancer therapy 

The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.

Read More
The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of the bone marrow.
Drugs Health Pharma

EMA recommends stopping sale of GSK’s blood cancer drug in EU

The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of

Read More
American voters who express negative opinions about academics are most likely to believe climate change is not caused by humans and is not a problem for the US, a study says.
Climate Health Pharma

41% of US voters say climate change doesn’t have a human cause

American voters who express negative opinions about academics are most likely to believe climate change is not caused by humans and is not

Read More
At least 23 people have died in Poland from Legionnaires' disease as of September 11, with a total of 166 cases being reported — the highest in seven years.
Drugs Health Pharma

Poland’s Legionnaires’ disease cases highest in 7 years

At least 23 people have died in Poland from Legionnaires' disease as of September 11, with a total of 166 cases being reported

Read More